Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Immune and pancreatic β cell interactions in type 1 diabetes

Boldison, Joanne and Wong, Florence Susan ORCID: https://orcid.org/0000-0002-2812-8845 2016. Immune and pancreatic β cell interactions in type 1 diabetes. Trends in Endocrinology & Metabolism 27 (12) , pp. 856-867. 10.1016/j.tem.2016.08.007

[thumbnail of TEM-D-FSWAccept.pdf]
Preview
PDF - Accepted Post-Print Version
Download (3MB) | Preview

Abstract

The autoimmune destruction of the pancreatic islet β cells is due to a targeted lymphocyte attack. Different T cell subsets communicate with each other and with the insulin-producing β cells in this process, with evidence not only of damage to the tissue cells but also of lymphocyte regulation. Here we explore the various components of the immune response as well as the cellular interactions that are involved in causing or reducing immune damage to the β cells. We consider these in the light of the possibility that understanding them may help us identify therapeutic targets to reduce the damage and destruction leading to type 1 diabetes. Trends In type 1 diabetes (T1D), β cells are highly sensitive to selective damage and recruit immune cells by chemokine production. These immune cells directly damage β cells and induce enzymes and cytokines that cause free radical- and cytokine-induced apoptosis. Damaged islets express innate immune receptors, engagement of which may amplify β cell destruction contributing to their own destruction. Interestingly, damaged and functional islets coexist. Immune regulatory cells and regulatory mechanisms induced by islet cells counterbalance inflammation. Communication between immune cells and resident islet β cells during inflammation is dependent on the pancreatic microenvironment. Therapeutically targeting the direct and indirect mediators of β cell damage to prevent further destruction combined with boosting β cell numbers and function are important joint targets in developing therapies for T1D.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Systems Immunity Research Institute (SIURI)
Subjects: R Medicine > R Medicine (General)
Uncontrolled Keywords: immune crosstalk; pancreatic islets; inflammation; type 1 diabetes; autoimmune disease
Publisher: Elsevier
ISSN: 1043-2760
Funders: MRC, EFSD, Diabetes UK, EU FP&
Date of First Compliant Deposit: 21 November 2016
Date of Acceptance: 25 August 2016
Last Modified: 07 Nov 2023 05:23
URI: https://orca.cardiff.ac.uk/id/eprint/96316

Citation Data

Cited 39 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics